◆ Clinical & Experimental Allergy2026-06-03· Medicine
Comparative Efficacy of Intranasal Corticosteroids and Antihistamines in Enhancing Paediatric Quality of Life in Allergic Rhinoconjunctivitis
Ellen Tameeris, Suzie J. van den Berg, Arthur M. Bohnen, Patrick J. E. Bindels, Gijs Elshout
原始摘要（英文原文）· Original abstract
Summary Daily intranasal corticosteroids improved quality of life most in adolescents (12–18 years) with seasonal allergic rhinoconjunctivitis. Antihistamines showed greater quality‐of‐life improvement than intranasal corticosteroids in children (6–11 years).
Comparative Efficacy of Intranasal Corticosteroids and Antihistamines in Enhancing Paediatric Quality of Life in Allergic Rhinoconjunctivitis — 科研速览 Science Skim